Incyte Historical Cash Flow
| INCY Stock | USD 51.74 0.09 0.17% |
Analysis of Incyte cash flow over time is an excellent tool to project Incyte future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 3.1 B or Depreciation of 86.8 M as it is a great indicator of Incyte ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Incyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Incyte is a good buy for the upcoming year.
Incyte |
About Incyte Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Incyte balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Incyte's non-liquid assets can be easily converted into cash.
Incyte Cash Flow Chart
Incyte Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Incyte Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Incyte's Cash Flows Other Operating is fairly stable compared to the past year. Change To Netincome is likely to rise to about 332.1 M in 2024, despite the fact that Change In Working Capital is likely to grow to (236.2 M). Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Incyte to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Incyte operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Incyte's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Incyte current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.At this time, Incyte's Cash Flows Other Operating is fairly stable compared to the past year. Change To Netincome is likely to rise to about 332.1 M in 2024, despite the fact that Change In Working Capital is likely to grow to (236.2 M).
Incyte cash flow statement Correlations
Click cells to compare fundamentals
Incyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Incyte cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 668.7M | (318.9M) | 544.4M | 894.0M | 262.1M | 275.2M | |
| Free Cash Flow | 632.6M | (312.0M) | 568.5M | 892.1M | 449.0M | 471.5M | |
| Change In Working Capital | 57.3M | (71.7M) | (14.6M) | 198.8M | (248.7M) | (236.2M) | |
| Begin Period Cash Flow | 1.2B | 1.8B | 1.5B | 2.1B | 3.0B | 3.1B | |
| Other Cashflows From Financing Activities | 16.7M | 7.8M | 9.8M | (6.4M) | (52.5M) | (49.9M) | |
| Depreciation | 54.5M | 51.8M | 57.8M | 67.9M | 82.7M | 86.8M | |
| Other Non Cash Items | (14.3M) | 13.5M | 40.2M | 117.1M | 7.9M | 7.5M | |
| Capital Expenditures | 78.1M | 187.4M | 181.0M | 77.8M | 47.5M | 42.9M | |
| Total Cash From Operating Activities | 710.7M | (124.6M) | 749.5M | 969.9M | 496.5M | 521.3M | |
| Net Income | 446.9M | (295.7M) | 948.6M | 340.7M | 597.6M | 627.5M | |
| Total Cash From Financing Activities | 45.7M | 71.7M | 6.2M | (794K) | (20.0M) | (19.0M) | |
| End Period Cash Flow | 1.8B | 1.5B | 2.1B | 3.0B | 3.2B | 3.4B | |
| Sale Purchase Of Stock | (16.8M) | (22.8M) | (29.9M) | (26.3M) | (28.6M) | (27.1M) | |
| Change To Inventory | (6.1M) | (19.5M) | (21.0M) | (67.5M) | (170.2M) | (178.7M) | |
| Stock Based Compensation | 166.6M | 177.9M | 183.0M | 188.4M | 215.9M | 226.7M | |
| Total Cashflows From Investing Activities | (87.5M) | (269.0M) | (207.7M) | (78.5M) | (70.7M) | (74.2M) | |
| Change To Account Receivables | (1.2M) | (173.2M) | (134.3M) | (28.6M) | (98.7M) | (93.7M) | |
| Investments | (9.4M) | (81.6M) | (26.7M) | (709K) | (74.1M) | (77.8M) | |
| Change Receivables | (1.2M) | (173.2M) | (134.3M) | (28.6M) | (25.7M) | (27.0M) | |
| Cash And Cash Equivalents Changes | 668.9M | (321.9M) | 548.0M | 890.6M | 1.0B | 1.1B | |
| Cash Flows Other Operating | (28.7M) | (18.5M) | (40.0M) | 56.9M | 65.4M | 68.6M | |
| Change To Netincome | 186.4M | 201.5M | (266.4M) | 275.0M | 316.3M | 332.1M | |
| Change To Liabilities | 58.9M | 129.0M | 204.8M | 325.6M | 374.5M | 393.2M | |
| Change To Operating Activities | 84.8M | 105.8M | 67.4M | 189.5M | 217.9M | 228.8M |
Incyte Investors Sentiment
The influence of Incyte's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Incyte. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Incyte's public news can be used to forecast risks associated with an investment in Incyte. The trend in average sentiment can be used to explain how an investor holding Incyte can time the market purely based on public headlines and social activities around Incyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Incyte's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Incyte's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Incyte's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Incyte.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Incyte in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Incyte's short interest history, or implied volatility extrapolated from Incyte options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Incyte Stock analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.324 | Earnings Share 2.65 | Revenue Per Share 16.526 | Quarterly Revenue Growth 0.093 | Return On Assets 0.0646 |
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.